The Pharma Data

JUNE 30, 2021

For their remarkable scientific contributions, doctoral student Julia Klaus, Zurich University VetSuisse Faculty, and Dr Yasmin Parr from the MRC-University of Glasgow, Centre for Virus Research, have received the 2021 ABCD Young Scientist Award. To foster young talent development in the feline health research community. References.

Scientist 52

Scientist Immune Response Antibody Development 52

STAT News

SEPTEMBER 30, 2022

The shortlist includes researchers who elucidated how cells make energy, those who discovered the chemical chatter of bacteria, many of the brilliant minds who shepherded us into the “ era of the genome ,” and most prominently, the pioneers behind the mRNA Covid vaccines. Read the rest…

Bacteria 124

Bacteria Genome Genomics Vaccination 124

Drug Discovery World

SEPTEMBER 1, 2022

Scottish scientists are teaming up with researchers from Zambia to find new ways to diagnose and treat a condition which affects millions in Sub-Saharan Africa. . EE is a disorder of the gut which scientists think plays an important role in malnutrition and stunted growth in children. Analysis of gut bacteria.

Research 52

Research Bacteria Scientist Nurses 52

pharmaphorum

NOVEMBER 25, 2020

AstraZeneca’s research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by accident. According to Reuters , the AstraZeneca development team made a minor mistake that made them realise they could significantly boost the success rate of the vaccine, codenamed AZD1222.

Vaccination 119

Vaccination Vaccine Bacteria RNA 119

Drug Discovery World

JULY 8, 2022

GSK’s ‘Vaccines for a sustainable planet’ meeting is gathering 65 experts across immunology, vaccinology, epidemiology, and policy throughout 7-8 July. . Other sessions will explore how to prioritise pathogens for antimicrobial resistance and the role of vaccines in protecting microbial diversity. . Official comments ? .

Vaccination 52

Vaccination Vaccine Allergies Bacteria 52

Pharmaceutical Technology

AUGUST 17, 2022

On August 8, Pfizer and Valneva announced the initiation of a Phase III study with their Lyme disease vaccine , bringing the prospect of an injection to prevent the condition disease one step closer to reality. Lyme disease is also known as borreliosis, which refers to the borrelia bacteria that cause the condition.

Vaccination 299

Vaccination Vaccine Bacteria Protein 299

Drug Discovery World

MARCH 14, 2023

For the first time, researchers have developed an mRNA vaccine that is 100% effective against a type of bacteria that is lethal to humans, paving the way for effective vaccination against antibiotic-resistant bacteria. However, until now scientists believed that mRNA vaccines against bacteria were biologically undoable.

Bacteria 59

Bacteria Vaccination Vaccine Protein 59

The Pharma Data

MAY 22, 2023

Pathogen genomics analyzes the genetic code of viruses, bacteria and other disease-causing organisms to understand how infectious they are, how deadly they are, and how they spread. Without the rapid sequencing of the SARS-COV-2 genome, vaccines would not have been as effective, or have been made available so quickly.

Genome 52

Genome Genomics Bioinformatics Bacteria 52

The Pharma Data

FEBRUARY 22, 2021

Born in 1970, the British and American research scientist has been Director of the Department of Microbiome Research at the Max Planck Institute for Developmental Biology in Tübingen since 2016. Now we are on the brink of a vaccination program of historic scale. This success is also a testament for the value of global collaboration.

Scientist 40

Scientist Life Science Research Gene Expression 40

XTalks

NOVEMBER 25, 2022

There are several strains of bacteria that have developed resistance to different types of antibiotics — these include MRSA (methicillin-resistant Staphylococcus aureus ) Clostridium difficile ( C. diff ) and the bacteria that cause multi-drug-resistant tuberculosis. According to the WHO, the silent pandemic leads to at least 1.3

Bacteria 98

Bacteria Life Science Development Production 98

The Pharma Data

MARCH 13, 2022

People who gained immunity – either through vaccination or exposure – against the original strain of SARS-CoV-2, the virus that causes COVID-19, also are likely to have some protection against the pathogen’s omicron variant. population.

Immune Response 52

Immune Response Protein Medicine Genetics 52

The Pharma Data

MARCH 23, 2022

In a study described March 18 in the Nature journal Communications Biology, the scientists showed that sulforaphane, a plant-derived chemical, known as a phytochemical, already found to have anti-cancer effects, can inhibit the replication of SARS-CoV-2, the coronavirus that causes COVID-19, and another human coronavirus in cells and mice.

Immune Response 52

Immune Response In-Vitro Research Scientist 52

Delveinsight

JULY 27, 2021

GlaxoSmithKline announced the US Food and Drug Administration approval for its vaccine, Shingrix (Zoster Vaccine Recombinant, Adjuvanted) under trials in 18+ adults who are vulnerable or at an increased risk to Shingles , which is already commercialized for patient group aged 50 and above.

Vaccination 96

Vaccination Vaccine Trials Manufacturing 96

Drug Discovery World

APRIL 30, 2024

The biggest growth driver for mRNA therapeutics came from the Covid-19 pandemic, when mRNA-based vaccines proved effective in treating SARS-CoV-2, and pharmaceutical companies such as Pfizer/BioNTech and Moderna were successful in bringing these treatments to market. mRNA is a molecule made up of a single strand of ribonucleic acid (RNA).

RNA 52

RNA Protein Vaccination Vaccine 52

The Pharma Data

JUNE 28, 2021

Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. ” About RINVOQ ® (upadacitinib).

Medicine 52

Medicine Drugs Bacteria FDA Approval 52

The Pharma Data

APRIL 3, 2021

Discovered and developed by AbbVie scientists, RINVOQ is a JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Serious infections have happened in some people taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body.

Drugs 52

Drugs Medicine Bacteria FDA Approval 52

The Pharma Data

MARCH 17, 2021

Discovered and developed by AbbVie scientists, RINVOQ is an oral, once daily, selective and reversible JAK inhibitor studied in several immune-mediated inflammatory diseases. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. vice chairman and president, AbbVie.

Drugs 52

Drugs Medicine Bacteria Vaccination 52

Drug Discovery World

MAY 6, 2024

Mazzetti and Schneider give the example of T3 Pharmaceuticals, a University of Basel spin-off that developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria.

Drugs 59

Drugs Life Science Gene Editing Gene 59

The Pharma Data

MAY 15, 2021

In fact, for 90% of gout sufferers scientists say it isn’t over-production of uric acid that is the problem. Scientists have long known food is a medicine. But what’s been happening since the 1980s is that scientists have steadily worked out why it’s a medicine. The bacteria in our gut make up what is called our ‘microbiome’.

Bacteria 52

Bacteria Doctors Doctor Production 52

The Pharma Data

APRIL 1, 2021

Discovered and developed by AbbVie scientists, RINVOQ is a JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Serious infections have happened in some people taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body.

Medicine 52

Medicine Doctors Doctor Bacteria 52

The Pharma Data

AUGUST 5, 2021

About Upadacitinib (RINVOQ ® ) 4 Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines.

Medicine 52

Medicine Dermatology Bacteria Vaccination 52

XTalks

NOVEMBER 9, 2021

Perhaps popularized by the COVID-19 vaccines, RNA-based technologies now have the potential to become the next best pesticide to combat crop pests, like insects and fungal pathogens. RNA interference (RNAi) is one such improvement that earned the scientists responsible for its discovery a Nobel Peace Prize in 2006.

RNA 98

RNA Gene Scientist Protein 98

The Pharma Data

JUNE 18, 2021

Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. About RINVOQ ® (upadacitinib).

Medicine 40

Medicine Production Trials Development 40

Drug Discovery World

APRIL 25, 2024

One of the most recent drivers of the cell line development market came from the Covid-19 pandemic, where research into vaccines skyrocketed and demand for cell lines was boosted as a result. HEK 293 cells on the other hand are used within viral vector productions which have wide-scale applications for vaccines and therapies.

Development 59

Development Protein In-Vivo Life Science 59

The Pharma Data

JUNE 30, 2021

Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. About Upadacitinib (RINVOQ ® ).

Medicine 52

Medicine Bacteria Vaccination Vaccine 52

Drug Discovery World

MAY 7, 2024

It was founded in 2020 to connect industry, academia and the NHS and help discover and develop new treatments, including diagnostics, vaccines and preventative products for infective diseases. baumannii and inhibits the LptB2FGC complex, the machinery that assembles the outer membrane of gram-negative bacteria.

Development 59

Development Medicine Marketing Production 59

The Pharma Data

MAY 15, 2021

But it’s now firmly understood by medical scientists that these apparently different conditions all have, at their source. For over a decade now medical scientists have realized that the primary cause of a long list of deadly western illnesses – including the ones that lead directly to neuropathy – is… the gut. a single cause.

Bacteria 52

Bacteria Production Doctors Doctor 52

The Pharma Data

FEBRUARY 22, 2021

Discovered and developed by AbbVie scientists, RINVOQ is an oral, once daily, selective and reversible JAK inhibitor studied in several immune-mediated inflammatory diseases. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. About Upadacitinib (RINVOQ).

Medicine 52

Medicine Development Drugs Trials 52

Druggist

SEPTEMBER 15, 2021

But, the way the virus is continuously mutating, is a problem for both scientists and doctors. But these days the vaccines being used to protect against covid are proving to be most effective. You should not receive any vaccines while using azithromycin unless your doctor tells you to. Cavalcanti AB 2020 , Sultana J 2020 ).

Doctors 52

Doctors Doctor Medicine Bacteria 52

Druggist

SEPTEMBER 15, 2021

But, the way the virus is continuously mutating, is a problem for both scientists and doctors. But these days the vaccines being used to protect against covid are proving to be most effective. You should not receive any vaccines while using azithromycin unless your doctor tells you to.

Doctors 52

Doctors Doctor Medicine Bacteria 52

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. billion in 2022. for a pediatric dose.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JANUARY 21, 2021

Pfizer-BioNTech COVID-19 Vaccine Effective Against UK Variant. Pfizer and BioNTech announced that their COVID-19 vaccine was probably just as effective against the variant strain of the virus, B.1.1.7, Scientists at KU Leuven have identified a biological mechanism behind irritable bowel syndrome (IBS) and other food intolerances.

Research 52

Research DNA Hormones Vaccination 52

Drug Discovery World

FEBRUARY 15, 2023

The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. A brief history of vaccines and vaccination. IO harnesses the capabilities of an activated immune system to target cancer cell killing. Front Immunol. 2017) 8:829. doi: 10.3389/fimmu.2017.00829

Research 52

Research In-Vitro In-Vivo Development 52

The Pharma Data

MAY 15, 2021

Now that scientists know what causes HCT we finally have the power to directly influence those causes. You may already be familiar with the discovery that our gut environment contains trillions of good, beneficial bacteria. What scientists know – and have proven – is that these various types of bacteria are beyond just ‘beneficial’.

Bacteria 52

Bacteria Gene Gene Therapy Gene Expression 52

XTalks

DECEMBER 24, 2020

From isolating SARS-CoV-2 in early January to sequencing its genome shortly thereafter and having a prototype vaccine against it within days, scientific process and progress have held steadfast throughout the pandemic. For example, investment in mRNA vaccines and viral vectors came well before January, many years before it.

Life Science 111

Life Science Vaccination Vaccine Gene 111

Pharmaceutical Technology

MARCH 24, 2023

Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.

Vaccination 162

Vaccination Vaccine Clinical Trials Clinical Trials 162

The Pharma Data

MAY 14, 2021

Fully vaccinated people can shed their masks in most places – CDC ( Reuters ) ( STAT ). US diplomats: Send vaccine overseas now or China, Russia will win out ( Politico ). Charles River loses a battle over harvesting horseshoe crabs used for testing bacteria in drugs ( STAT ).

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52